Time‑dependent ROC curve analysis to determine the predictive capacity of seven clinical scales for mortality in patients with COVID‑19: Study of a hospital cohort with very high mortality.

COVID-19 ROC curve hospital mortality sensitivity severity of illness index specificity

Journal

Biomedical reports
ISSN: 2049-9442
Titre abrégé: Biomed Rep
Pays: England
ID NLM: 101613227

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 12 02 2024
accepted: 12 04 2024
medline: 20 5 2024
pubmed: 20 5 2024
entrez: 20 5 2024
Statut: epublish

Résumé

Clinical data from hospital admissions are typically utilized to determine the prognostic capacity of Coronavirus disease 2019 (COVID-19) indices. However, as disease status and severity markers evolve over time, time-dependent receiver operating characteristic (ROC) curve analysis becomes more appropriate. The present analysis assessed predictive power for death at various time points throughout patient hospitalization. In a cohort study involving 515 hospitalized patients (General Hospital Number 1 of Mexican Social Security Institute, Colima, Mexico from February 2021 to December 2022) with COVID-19, seven severity indices [Pneumonia Severity Index (PSI) PaO

Identifiants

pubmed: 38765855
doi: 10.3892/br.2024.1788
pii: BR-20-6-01788
pmc: PMC11099607
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100

Informations de copyright

Copyright: © 2024 Mendoza-Hernandez et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Martha A Mendoza-Hernandez (MA)

Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
COVID Unit, General Hospital Number 1, Mexican Institute of Social Security, Villa de Alvarez, Colima 28984, Mexico.

Gustavo A Hernandez-Fuentes (GA)

Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.

Carmen A Sanchez-Ramirez (CA)

Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.

Fabian Rojas-Larios (F)

Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.

Jose Guzman-Esquivel (J)

Clinical Epidemiology Research Unit, Mexican Institute of Social Security, Villa de Alvarez, Colima 28984, Mexico.

Iram P Rodriguez-Sanchez (IP)

Molecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo Leon, San Nicolas de los Garza 66455, Mexico.

Margarita L Martinez-Fierro (ML)

Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, Mexico.

Martha I Cardenas-Rojas (MI)

Clinical Epidemiology Research Unit, Mexican Institute of Social Security, Villa de Alvarez, Colima 28984, Mexico.
Department of Research, Colima Cancerology State Institute, IMSS-Bienestar Colima, Colima 28085, Mexico.

Luis De-Leon-Zaragoza (L)

Department of Research, Colima Cancerology State Institute, IMSS-Bienestar Colima, Colima 28085, Mexico.

Benjamin Trujillo-Hernandez (B)

Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.

Mercedes Fuentes-Murguia (M)

Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.

Héctor Ochoa-Díaz-López (H)

Department of Health, El Colegio de La Frontera Sur, San Cristóbal de Las Casas, 29290 Chiapas, Mexico.

Karmina Sánchez-Meza (K)

Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.

Ivan Delgado-Enciso (I)

Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Department of Research, Colima Cancerology State Institute, IMSS-Bienestar Colima, Colima 28085, Mexico.

Classifications MeSH